• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

ASAP Optimization of PEGylated KL4 Peptide for siRNA Delivery with Improved Pulmonary Tolerance
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.0c01242
Source: Molecular Pharmaceutics - May 20, 2021 Category: Drugs & Pharmacology Authors: Yingshan Qiu, Maria Clarke, Leon T. L. Wan, Jason C. K. Lo, A. James Mason, and Jenny K. W. Lam Source Type: research

ASAP Treatment of Melanoma by Nano-conjugate-Delivered Wee1 siRNA
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.1c00316
Source: Molecular Pharmaceutics - August 10, 2021 Category: Drugs & Pharmacology Authors: Xueyan Zhang, Anqi Cai, Yan Gao, Yuanfa Zhang, Xingmei Duan, and Ke Men Source Type: research

ASAP Intraperitoneal siRNA Nanoparticles for Augmentation of Gemcitabine Efficacy in the Treatment of Pancreatic Cancer
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.1c00653
Source: Molecular Pharmaceutics - October 26, 2021 Category: Drugs & Pharmacology Authors: Siyuan Tang, Yu Hang, Ling Ding, Weimin Tang, Ao Yu, Chuhan Zhang, Diptesh Sil, Ying Xie, and David Oupicky ́ Source Type: research

ASAP Redox-Responsive Disulfide Cyclic Peptides: A New Strategy for siRNA Delivery
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.1c00879
Source: Molecular Pharmaceutics - March 29, 2022 Category: Drugs & Pharmacology Authors: Dindyal Mandal, Eman H. M. Mohammed, Sandeep Lohan, Parvin Mandipoor, Darius Baradaran, Rakesh K. Tiwari, Keykavous Parang, and Hamidreza Montazeri Aliabadi Source Type: research

ASAP Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00033
Source: Molecular Pharmaceutics - June 1, 2022 Category: Drugs & Pharmacology Authors: Francesca Ferraresso, Amy W. Strilchuk, Lih Jiin Juang, Lauren G. Poole, James P. Luyendyk, and Christian J. Kastrup Source Type: research

ASAP Efficacy of Asymmetric siRNA Targeting Androgen Receptors for the Treatment of Androgenetic Alopecia
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00510
Source: Molecular Pharmaceutics - November 10, 2022 Category: Drugs & Pharmacology Authors: Ik Jun Moon, Hae Kyeong Yoon, Doyeun Kim, Myung Eun Choi, Seung Hee Han, June Hyun Park, Sun Woo Hong, Hyesoo Cho, Dong-Ki Lee, and Chong Hyun Won Source Type: research

ASAP Recent Advancements in the Design of Nanodelivery Systems of siRNA for Cancer Therapy
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00811
Source: Molecular Pharmaceutics - November 21, 2022 Category: Drugs & Pharmacology Authors: Dokkari Nagalaxmi Yadav, Mohammad Sadik Ali, Ajinkya Madhukar Thanekar, Sunil Venkanna Pogu, and Aravind Kumar Rengan Source Type: research

ASAP Layer-by-Layer Particles Deliver Epigenetic Silencing siRNA to HIV ‑1 Latent Reservoir Cell Types
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01030
Source: Molecular Pharmaceutics - February 27, 2023 Category: Drugs & Pharmacology Authors: Ewa Czuba-Wojnilowicz, Vera Klemm, Christina Cortez-Jugo, Stuart Turville, Anupriya Aggarwal, Frank Caruso, Anthony D. Kelleher, and Chantelle L. Ahlenstiel Source Type: research

ASAP Development of Cationic Lipid LAH4-L1 siRNA Complexes for Focused Ultrasound Enhanced Tumor Uptake
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00909
Source: Molecular Pharmaceutics - March 29, 2023 Category: Drugs & Pharmacology Authors: Shahd Abuhelal, Miguel N. Centelles, Michael Wright, A. James Mason, and Maya Thanou Source Type: research

Pages: 1  2  3  4  5  6  7